Proye C, Vix M, Goropoulos A, Carnaille B, Vermesse B, Kerlo P, Lecomte-Houcke M
Clinique chirurgicale adultes Est, CHU de Lille, Hôpital Huriez.
Chirurgie. 1992;118(8):433-8.
In a 20 year period, from 1971 through 1991, 105 chromaffin tumours--excluding cervical ones--were operated by the same surgeon: 50 during the first 15 years and 55 during the last 5 years. Pheochromocytomas are defined as intra-adrenal chromaffin tumours, and paragangliomas--or ectopic pheochromocytomas--as of extra-adrenal location. Among those tumours, 30 were malignant (i.e. metastatic) and 75 benign. Among the 30 malignant tumours, 14 were ectopic, 2 occurred in a MEN II A setting and were bilateral, 2 were associated with liver adenoma and liver hemangioma respectively suggesting Von Hippel-Lindau syndrome, and one case was associated with a seemingly sporadic primary hyperparathyroidism. 9 out of those 30 malignancies were not associated with hypertension. Among 75 benign pheochromocytomas or paragangliomas, 10 were ectopic, 7 occurred in a MEN setting (6 type II, 1 type I). 3 patients without evidence of MEN or other neuroectodermal abnormalities presented bilateral pheochromocytoma, either synchronous (2) or metachronous (1). 7 cases occurred in a Von Hippel-Lindau syndrome (3 bilateral) and 4 in a neurofibromatosis setting (1 bilateral). 3 other cases were familial without evidence of MEN (including a case of triple tumour: bilateral and ectopic and another ectopic case). 2 other cases were associated with seemingly sporadic hyperparathyroidism. As a whole, in 34 of 75 benign pheochromocytomas or paragangliomas, the tumour was not intra-adrenal, unilateral and sporadic. Among those 75 tumours, 22 were not overtly hypertensive, including 10 out of the 41 seemingly intra-adrenal, solitary and sporadic. The pheochromocytoma, benign, intra-adrenal sporadic, hypertensive accounts for no more than 30% of the subphrenic catecholamine-secretin chromaffin tumours.(ABSTRACT TRUNCATED AT 250 WORDS)
在1971年至1991年的20年期间,同一位外科医生对105例嗜铬细胞瘤(不包括颈部的)进行了手术:前15年有50例,后5年有55例。嗜铬细胞瘤定义为肾上腺内嗜铬细胞瘤,而副神经节瘤(或异位嗜铬细胞瘤)为肾上腺外部位的肿瘤。在这些肿瘤中,30例为恶性(即转移性),75例为良性。在30例恶性肿瘤中,14例为异位性,2例发生在MEN II A综合征背景下且为双侧性,2例分别与肝腺瘤和肝血管瘤相关,提示为冯·希佩尔-林道综合征,1例与看似散发性原发性甲状旁腺功能亢进相关。这30例恶性肿瘤中有9例与高血压无关。在75例良性嗜铬细胞瘤或副神经节瘤中,10例为异位性,7例发生在MEN综合征背景下(6例为II型,1例为I型)。3例无MEN或其他神经外胚层异常证据的患者出现双侧嗜铬细胞瘤,为同步性(2例)或异时性(1例)。7例发生在冯·希佩尔-林道综合征(3例为双侧性),4例发生在神经纤维瘤病背景下(1例为双侧性)。另外3例为家族性,无MEN证据(包括1例三联瘤:双侧性且异位,另1例为异位性)。另外2例与看似散发性甲状旁腺功能亢进相关。总体而言,75例良性嗜铬细胞瘤或副神经节瘤中,有34例肿瘤并非肾上腺内、单侧且散发性的。在这75例肿瘤中,22例并非明显高血压,其中41例看似肾上腺内、孤立且散发性的肿瘤中有10例。良性、肾上腺内散发性、高血压性嗜铬细胞瘤在膈下儿茶酚胺分泌性嗜铬细胞瘤中所占比例不超过30%。(摘要截选至250词)